REGENERON PHARMACEUTICALS, INC. quarter change: USA Other Stocks, Sold out
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), from the quarter ended 2026-03-31 to 2026-06-30, REGENERON PHARMACEUTICALS, INC. opened 0 positions, added to 0, reduced 0, sold out of 1 and left 0 unchanged. The largest increase in value was Adicet Bio, Inc. (-$412,080); the largest decrease was Adicet Bio, Inc. (-$412,080).
- Adicet Bio, Inc.: Country of operation United States; Class Common Stock; Shares 2026-03-31 60,511; Shares 2026-06-30 0.
Two Form 13F-HR filings compared (SEC CIK 872589): 2026-03-31 (filed 2026-05-08) and 2026-06-30 (filed 2026-08-07). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Portland Financial Advisors Inc | United States | $0.048B | 77 |
| Vickerman Investment Advisors, Inc. | United States | $0.048B | 94 |
| Inflection Point Holdings II LLC | United States | $0.047B | 1 |
| FLP Wealth Management, LLC | United States | $0.049B | 53 |
| Capital CS Group, LLC | United States | $0.049B | 61 |
| Global IMC LLC | United States | $0.047B | 16 |
| ClearAlpha Technologies LP | United States | $0.049B | 74 |
| PICKERING ENERGY PARTNERS LP | United States | $0.047B | 19 |
| Firsthand Capital Management, Inc. | United States | $0.047B | 47 |
| New Paradigm Capital Management, LLC | United States | $0.047B | 15 |